Literature DB >> 19631660

cAMP prevents glucose-mediated modifications of histone H3 and recruitment of the RNA polymerase II holoenzyme to the L-PK gene promoter.

Susan J Burke1, J Jason Collier, Donald K Scott.   

Abstract

Glucose and cAMP reciprocally regulate expression of the L-type pyruvate kinase (L-PK) gene by controlling the formation of a complex containing the carbohydrate response element binding protein (ChREBP) and the coactivator CREB binding protein (CBP) on the L-PK promoter. However, the role of posttranslational histone modifications on the opposing effects of glucose and cAMP on the L-PK gene is unknown. Using the highly glucose-sensitive 832/13 rat insulinoma cell line, we demonstrated that glucose regulates acetylation and methylation of various histone residues at the L-PK gene promoter. These glucose-dependent histone modifications correlated with an increase in the recruitment and phosphorylation of RNA polymerase II (Pol II) on the L-PK gene promoter. Conversely, the cAMP agonist forskolin prevented glucose-mediated expression of the L-PK gene by decreasing the acetylation of histones H3 and H4 on the promoter, decreasing the methylation of H3-K4 on the coding region, and increasing the methylation of H3-K9 on the coding region. These changes induced by cAMP culminated with a decrease in the glucose-dependent recruitment of phosphorylated Pol II to the L-PK gene promoter. Furthermore, maneuvers that interfere with the glucose-dependent assembly of ChREBP and CBP on the L-PK promoter, such as increasing intracellular cAMP levels, overexpression of a dominant-negative form of ChREBP, and small-interfering-RNA-mediated suppression of CBP abundance, all altered the acetylation and methylation of histones on the L-PK promoter, which decreased Pol II recruitment and subsequently inhibited transcriptional activation of the L-PK gene. We conclude that the effects of glucose and cAMP are mediated in part by epigenetic modulation of histones.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631660      PMCID: PMC2771933          DOI: 10.1016/j.jmb.2009.07.053

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  46 in total

1.  Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly.

Authors:  J Nakayama ; J C Rice; B D Strahl; C D Allis; S I Grewal
Journal:  Science       Date:  2001-03-15       Impact factor: 47.728

2.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

3.  Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena.

Authors:  B D Strahl; R Ohba; R G Cook; C D Allis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 4.  Histone acetylation and an epigenetic code.

Authors:  B M Turner
Journal:  Bioessays       Date:  2000-09       Impact factor: 4.345

Review 5.  Coordination between transcription and pre-mRNA processing.

Authors:  P Cramer; A Srebrow; S Kadener; S Werbajh; M de la Mata; G Melen; G Nogués; A R Kornblihtt
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

6.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.

Authors:  A J Bannister; P Zegerman; J F Partridge; E A Miska; J O Thomas; R C Allshire; T Kouzarides
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

7.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.

Authors:  M Lachner; D O'Carroll; S Rea; K Mechtler; T Jenuwein
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

8.  Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.

Authors:  H E Hohmeier; H Mulder; G Chen; R Henkel-Rieger; M Prentki; C B Newgard
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

9.  Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity.

Authors:  Michael N Davies; Brennon L O'Callaghan; Howard C Towle
Journal:  J Biol Chem       Date:  2008-06-30       Impact factor: 5.157

10.  c-Myc and ChREBP regulate glucose-mediated expression of the L-type pyruvate kinase gene in INS-1-derived 832/13 cells.

Authors:  J Jason Collier; Pili Zhang; Kim B Pedersen; Susan J Burke; John W Haycock; Donald K Scott
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-06       Impact factor: 4.310

View more
  13 in total

1.  ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells.

Authors:  Michael Boergesen; Lars la Cour Poulsen; Søren Fisker Schmidt; Francesca Frigerio; Pierre Maechler; Susanne Mandrup
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

2.  Dynamic changes in genomic histone association and modification during activation of the ASNS and ATF3 genes by amino acid limitation.

Authors:  Mukundh N Balasubramanian; Jixiu Shan; Michael S Kilberg
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

3.  c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes.

Authors:  Pili Zhang; Mallikarjurna R Metukuri; Sharell M Bindom; Edward V Prochownik; Robert M O'Doherty; Donald K Scott
Journal:  Mol Endocrinol       Date:  2010-04-09

4.  Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset.

Authors:  Susan J Burke; Michael D Karlstad; Adrianna E Eder; Kellie M Regal; Danhong Lu; David H Burk; J Jason Collier
Journal:  Biofactors       Date:  2016-06-21       Impact factor: 6.113

5.  Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.

Authors:  Julien Bricambert; Jonatan Miranda; Fadila Benhamed; Jean Girard; Catherine Postic; Renaud Dentin
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

6.  Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.

Authors:  Sandrine Caron; Carolina Huaman Samanez; Hélène Dehondt; Maheul Ploton; Olivier Briand; Fleur Lien; Emilie Dorchies; Julie Dumont; Catherine Postic; Bertrand Cariou; Philippe Lefebvre; Bart Staels
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

7.  KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading.

Authors:  Anna C Groner; Sylvain Meylan; Angela Ciuffi; Nadine Zangger; Giovanna Ambrosini; Nicolas Dénervaud; Philipp Bucher; Didier Trono
Journal:  PLoS Genet       Date:  2010-03-05       Impact factor: 5.917

8.  Activation of carbohydrate response element-binding protein by ethanol.

Authors:  Suthat Liangpunsakul; Ruth A Ross; David W Crabb
Journal:  J Investig Med       Date:  2013-02       Impact factor: 2.895

9.  Hepatic IKKε expression is dispensable for high-fat feeding-induced increases in liver lipid content and alterations in glucose tolerance.

Authors:  J Jason Collier; Heidi M Batdorf; Tamra M Mendoza; David H Burk; Thomas M Martin; Jingying Zhang; Randall L Mynatt; Susan J Burke
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-10-29       Impact factor: 4.310

10.  Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α.

Authors:  Eric A Hanse; Douglas G Mashek; Jennifer R Becker; Ashley D Solmonson; Lisa K Mullany; Mara T Mashek; Howard C Towle; Anhtung T Chau; Jeffrey H Albrecht
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.